Abbott’s Cloherty On Viral Surveillance And Evolving Viruses
Executive Summary
Gavin Cloherty, Abbott’s head of infectious disease research, tells Scrip how the company’s global viral surveillance program helps it stay ahead of HIV and hepatitis evolution, outlines efforts at a partnership in India on viral diversity to help improve diagnostic accuracy and shares new findings from the company’s virus discovery program.
You may also be interested in...
Cyber-Attacked Dr Reddy’s Keeps Eye On Sputnik Plans
Dr Reddy’s management clears air on ransomware attack and says all critical operations are being enabled in a 'controlled and cautious' manner. The Indian firm also shared a timeline for its partnered Russian COVID-19 vaccine amid a free supply chorus in India.
Cyberattacked Dr. Reddy’s Keeps Eye On Sputnik Plans
Dr Reddy’s management clears air on ransomware attack and says all critical operations are being enabled in a 'controlled and cautious' manner. The Indian firm also shared a timeline for its partnered Russian COVID-19 vaccine amid a free supply chorus in India.
The Golden Winged Warbler And Creating Pharma Supply Chain Immunity
Expert outlines how pharma can create resilient and secure supply chains and some benefits of localization.
Need a specific report? 1000+ reports available
Buy Reports